To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (In development)
NICE

Jun. 13 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Invitation to participate
Document: Final scope PDF 176 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Jun. 13 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Invitation to participate
Document: NICE's response to comments on the draft scope and provisional stakeholder list PDF 539 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Jun. 13 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Invitation to participate
Document: Final stakeholder list PDF 190 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Jun. 13 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Invitation to participate
Document: Equality impact assessment (Scoping) PDF 136 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Mar. 28 2024

Source Page: Vamorolone for treating Duchenne muscular dystrophy [ID4024]
Publication Type: Draft guidance
Document: Equality impact assessment (PDF Version) PDF 155 KB (webpage)

Found: Vamorolone for treating Duchenne muscular dystrophy [ID4024]


Arms Length Body Publication (In development)
NICE

Mar. 28 2024

Source Page: Vamorolone for treating Duchenne muscular dystrophy [ID4024]
Publication Type: Draft guidance
Document: Public committee slides PDF 686 KB (webpage)

Found: Vamorolone for treating Duchenne muscular dystrophy [ID4024]


Arms Length Body Publication (In development)
NICE

Apr. 09 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6323
Document: Draft scope post referral PDF 183 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Mar. 28 2024

Source Page: Vamorolone for treating Duchenne muscular dystrophy [ID4024]
Publication Type: Draft guidance
Document: Draft guidance (PDF version) PDF 328 KB (webpage)

Found: Vamorolone for treating Duchenne muscular dystrophy [ID4024]


Arms Length Body Publication (In development)
NICE

Apr. 09 2024

Source Page: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
Publication Type: Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6323
Document: Draft matrix post referral PDF 188 KB (webpage)

Found: Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]


Arms Length Body Publication (In development)
NICE

Jan. 18 2024

Source Page: Delandistrogene moxeparvovec for treating Duchenne muscular dystrophy in children 4 to 7 years ID 3897
Publication Type: Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 3897
Document: Draft scope post referral PDF 180 KB (webpage)

Found: Delandistrogene moxeparvovec for treating Duchenne muscular dystrophy in children 4 to 7 years ID 3897